<VariationArchive RecordType="classified" VariationID="988031" VariationName="NM_000485.3(APRT):c.23dup (p.Val9fs)" VariationType="Duplication" Accession="VCV000988031" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2020-12-11" MostRecentSubmission="2020-12-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="976001" VariationID="988031">
      <GeneList>
        <Gene Symbol="APRT" FullName="adenine phosphoribosyltransferase" GeneID="353" HGNC_ID="HGNC:626" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88809339" stop="88811928" display_start="88809339" display_stop="88811928" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88875876" stop="88878341" display_start="88875876" display_stop="88878341" Strand="-" />
          </Location>
          <OMIM>102600</OMIM>
        </Gene>
        <Gene Symbol="LOC130059760" FullName="ATAC-STARR-seq lymphoblastoid silent region 7879" GeneID="130059760" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88811681" stop="88812080" display_start="88811681" display_stop="88812080" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000485.3(APRT):c.23dup (p.Val9fs)</Name>
      <CanonicalSPDI>NC_000016.10:88811876:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88811876" stop="88811877" display_start="88811876" display_stop="88811877" variantLength="1" positionVCF="88811876" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88878284" stop="88878285" display_start="88878284" display_stop="88878285" variantLength="1" positionVCF="88878284" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>V9fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.88811877dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.88811877dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.88878285dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.88878285dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008013.1" sequenceAccession="NG_008013" sequenceVersion="1" change="g.5058dup">
            <Expression>NG_008013.1:g.5058dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008667.1" sequenceAccession="NG_008667" sequenceVersion="1" change="g.50090dup">
            <Expression>NG_008667.1:g.50090dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000485.3" sequenceAccession="NM_000485" sequenceVersion="3" change="c.23dup" MANESelect="true">
            <Expression>NM_000485.3:c.23dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000476.1" sequenceAccession="NP_000476" sequenceVersion="1" change="p.Val9fs">
            <Expression>NP_000476.1:p.Val9fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001030018.2" sequenceAccession="NM_001030018" sequenceVersion="2" change="c.23dup">
            <Expression>NM_001030018.2:c.23dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001025189.1" sequenceAccession="NP_001025189" sequenceVersion="1" change="p.Val9fs">
            <Expression>NP_001025189.1:p.Val9fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1261219212" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00003" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00004" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000485.3(APRT):c.23dup (p.Val9fs) AND Adenine phosphoribosyltransferase deficiency" Accession="RCV001269423" Version="1">
        <ClassifiedConditionList TraitSetID="8113">
          <ClassifiedCondition DB="MedGen" ID="C0268120">Adenine phosphoribosyltransferase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-09-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-12-11" MostRecentSubmission="2020-12-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="8113" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6494" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dihydroxyadeninuria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Adenine phosphoribosyltransferase deficiency</ElementValue>
                <XRef ID="MONDO:0013869" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">UROLITHIASIS, 2,8-DIHYDROXYADENINE</ElementValue>
                <XRef Type="MIM" ID="614723" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEPHROLITHIASIS, DHA</ElementValue>
                <XRef Type="MIM" ID="614723" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">APRTD</ElementValue>
                <XRef Type="MIM" ID="614723" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Adenine phosphoribosyltransferase (APRT) deficiency is characterized by excessive production and renal excretion of 2,8-dihydroxyadenine (DHA), which leads to kidney stone formation and crystal-induced kidney damage (i.e., DHA crystal nephropathy) causing acute kidney injury episodes and progressive chronic kidney disease (CKD). Kidney stones, the most common clinical manifestation of APRT deficiency, can occur at any age; in at least 50% of affected persons symptoms do not occur until adulthood. If adequate treatment is not provided, approximately 20%-25% of affected individuals develop end-stage renal disease (ESRD), usually in adult life.</Attribute>
                <XRef ID="NBK100238" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="546" />
                <XRef ID="546" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22934314</ID>
                <ID Source="BookShelf">NBK100238</ID>
              </Citation>
              <XRef ID="976" DB="Orphanet" />
              <XRef ID="C0268120" DB="MedGen" />
              <XRef ID="MONDO:0013869" DB="MONDO" />
              <XRef Type="MIM" ID="614723" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2861983" SubmissionDate="2020-11-13" DateLastUpdated="2020-12-11" DateCreated="2020-12-11">
        <ClinVarSubmissionID localKey="NM_000485.2:c.23dup|OMIM:614723" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001449060" DateUpdated="2020-12-11" DateCreated="2020-12-11" Type="SCV" Version="1" SubmitterName="APRT Deficiency Research Program of the Rare Kidney Stone Consortium, Landspitali, National University Hospital of Iceland" OrgID="507801" OrganizationCategory="patient registry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APRT" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000485.2:exon 1</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000485.2:c.23dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614723" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8542258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2861983" TraitType="Disease" MappingType="XRef" MappingValue="614723" MappingRef="OMIM">
        <MedGen CUI="C0268120" Name="Adenine phosphoribosyltransferase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

